Clinical Case Database / Category: Patient Management

Brain tumour treatment options

Publication details

Dr Timothy Simmons, Dr Caroline Bridgewater, Dr Matthew Hatton
Foundation Years Journal, volume 6, issue 9, p.50 (123Doc Education, London, October 2012)

Abstract

As with almost any cancer presentation, brain tumours are a diverse group of diseases with widely varying morbidities, prognoses and treatment options. The most common tumours found in the brain are metastases from an extracranial site (1) - approximately 8.3 per 100,000 compared with 6.6 per 100,000 for primary brain tumours. However, primary brain tumours are the second most common childhood cancer and the most common solid tumour in children (2), with different treatment options and a superior prognosis compared to adult tumours. Treatment modalities for brain tumours include surgery, chemotherapy, radiotherapy and supportive care. This article will give an overview of the care of adult patients with central nervous system (CNS) metastatic disease and some of the more common primary brain tumours including high and low grade gliomas.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

Dr Timothy Simmons

-

Dr Caroline Bridgewater

-

Dr Matthew Hatton

-

References

1. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. Journal of clinical oncology. 2004 Jul 15;22(14):2865–72.
2. McKinney P a. Brain tumours: incidence, survival, and aetiology. Journal of Neurology, Neurosurgery & Psychiatry. 2004 Jun 1;75(suppl_2):ii12–ii17.
3. Grant R. Overview: brain tumour diagnosis and management/Royal College of Physicians guidelines. Journal of Neurology, Neurosurgery & Psychiatry. 2004 Jun 1;75(suppl_2):ii18–ii23.
4. Espay AJ. Emedicine: Hydrocephalus [Internet]. Available from: http:// emedicine.medscape.com/article/1135286-overview
5. Chamberlain MC. Neoplastic meningitis. The oncologist. 2008 Sep;13(9):967–77.
6. Eastern Cooperative Oncology Group. ECOG Performance Status [Internet]. Available from: http://ecog.dfci.harvard.edu/general/perf_stat.html
7. DVLA. At a glance guide to the current medical standards of fitness to drive. Available from: http://www.dft.gov.uk/dvla/medical/ataglance.aspx. [Internet].
8. Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of neuro-oncology. 2010 Jan;96(1):103–14.
9. Weller M. Glucocorticoid Treatment of Primary CNS Lymphoma. Journal of Neuro-Oncology. 1999;43(3):237–9.
10. Erdag N, Bhorade RM, Alberico RA, Yousuf N, Patel MR. Primary Lymphoma of the Central Nervous System : Typical and Atypical CT and MR Imaging Appearances. American Journal of Roentgenology. 2001;165(5):1319–26.
11. Vecht CJ, Breemen MV. Optimizing therapy of seizures in patients with brain tumors. Nerology. 2006;67(s4):s10–s13.
12. Butowski N. Medical management of brain metastases. Neurosurgery clinics of North America. 2011 Jan;22(1):27–36, v-vi.
13. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The lancet oncology. 2009 May;10(5):459–66.
14. Richardson MP, Strange B a, Thompson PJ, Baxendale S a, Duncan JS, Dolan RJ. Pre-operative verbal memory fMRI predicts post-operative memory decline after left temporal lobe resection. Brain : a journal of neurology. 2004 Nov;127(Pt 11):2419–26.
15. Bulsara K, Johnson J, Villavicencio A. Improvements in brain tumor
surgery : the modern history of awake craniotomies. Neurosurgical Focus. 2005;18(4):1–3.
16. NICE. Improving Outcomes for People with Brain and Other CNS Tumours [Internet]. NICE; 2006. Available from: http://guidance.nice.org.uk/ CSGBraincns/Guidance/pdf/English
17. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. Journal of neuro-oncology. 2010 Jan;96(1):45–68.
18. Marcus R, Hodson D, Coupland S, Bessell E, Mead B, Pettitt AR. Guidelines on the diagnosis and management of adult patients with primary CNS lymphoma ( PCNSL ) and primary intra-ocular lymphoma ( PIOL ). :1–33. Available from: http://www.bcshguidelines.com/documents/PCNSL__bcsh_2007.pdf [Internet].
19. Nussbaum E, Djalilian H, Cho K, Hall W. Brain Metastases - Histology, Multiplicity, Surgery and Survival. Cancer. 1996;88(8):1781–8.
20. Al-Shamy G, Sawaya R. Management of brain metastases: the indispensable role of surgery. Journal of neuro-oncology. 2009 May;92(3):275–82.
21. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, et al. Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain. JAMA. 1998;280(17):1485–9.
22. Thomas SS, Dunbar EM. Modern multidisciplinary management of brain metastases. Current oncology reports [Internet]. 2010 Jan [cited 2012 Mar 17];12(1):34–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20425606
23. Tsao M, Lloyd N, Rks W, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases ( Review ). The Cochrane Library. 2009;(1).
24. MRCUK. Quality of Life After Treatment for Brain Metastases: Interim Data Release [Internet]. Available from: http://www.ctu.mrc.ac.uk/pdf/Qz_interim results_shortened presentation.pdf
25. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica. 2007 Aug;114(2):97–109.
26. Lin C., Lieu A., Lee K., Yang YH., Kuo T., Hung M., et al. The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme. Surgical Neurology. 2003 Nov;60(5):402–6.
27. Kappelle a C, Postma TJ, Taphoorn MJ, Groeneveld GJ, van den Bent MJ, van Groeningen CJ, et al. PCV chemotherapy for recurrent glioblastoma multiforme. Neurology. 2001 Jan 9;56(1):118–20.
28. Whittle IR. The dilemma of low grade glioma. Journal of Neurology, Neurosurgery & Psychiatry. 2004 Jun 1;75(suppl_2):ii31–ii36.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.